➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKinsey
Harvard Business School
Dow
Medtronic

Last Updated: October 26, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VOLTAREN-XR

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Voltaren-xr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00171691 Safety of Diclofenac Sodium Gel in Knee Osteoarthritis Completed Novartis Phase 3 2004-10-01 This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.
NCT00276419 Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin Terminated Mayo Clinic Phase 2/Phase 3 2005-06-01 The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
NCT00310908 Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic Completed Grumental Phase 4 2006-09-01 The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Voltaren-xr

Condition Name

Condition Name for Voltaren-xr
Intervention Trials
Pain 10
Osteoarthritis 3
Osteoarthritis, Knee 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Voltaren-xr
Intervention Trials
Osteoarthritis 7
Osteoarthritis, Knee 6
Renal Colic 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Voltaren-xr

Trials by Country

Trials by Country for Voltaren-xr
Location Trials
United States 40
India 13
Egypt 6
Germany 6
Poland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Voltaren-xr
Location Trials
Texas 3
California 3
Virginia 2
Tennessee 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Voltaren-xr

Clinical Trial Phase

Clinical Trial Phase for Voltaren-xr
Clinical Trial Phase Trials
Phase 4 12
Phase 3 13
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Voltaren-xr
Clinical Trial Phase Trials
Completed 20
Recruiting 13
Not yet recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Voltaren-xr

Sponsor Name

Sponsor Name for Voltaren-xr
Sponsor Trials
Cairo University 4
GlaxoSmithKline 2
Assiut University 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Voltaren-xr
Sponsor Trials
Other 33
Industry 25
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Johnson and Johnson
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.